Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1979 2
1980 5
1981 4
1982 10
1983 6
1984 5
1985 3
1986 9
1987 12
1988 9
1989 8
1990 9
1991 16
1992 13
1993 15
1994 13
1995 22
1996 13
1997 18
1998 14
1999 14
2000 19
2001 14
2002 18
2003 20
2004 28
2005 26
2006 32
2007 40
2008 40
2009 43
2010 56
2011 58
2012 55
2013 57
2014 45
2015 52
2016 45
2017 45
2018 46
2019 39
2020 28
Text availability
Article attribute
Article type
Publication date

Search Results

927 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
The safety of intrauterine devices among young women: a systematic review.
Jatlaoui TC, Riley HEM, Curtis KM. Jatlaoui TC, et al. Contraception. 2017 Jan;95(1):17-39. doi: 10.1016/j.contraception.2016.10.006. Epub 2016 Oct 19. Contraception. 2017. PMID: 27771475 Free PMC article. Review.
OBJECTIVE: The objective was to determine the association between use of intrauterine devices (IUDs) by young women and risk of adverse outcomes. ...Two studies (Level II-2, fair) examined risks of expulsion among younger compared with older women using levonorge
OBJECTIVE: The objective was to determine the association between use of intrauterine devices (IUDs) by young women and risk o …
Levonorgestrel-releasing intra-uterine systems as female contraceptives.
Grandi G, Farulla A, Sileo FG, Facchinetti F. Grandi G, et al. Expert Opin Pharmacother. 2018 May;19(7):677-686. doi: 10.1080/14656566.2018.1462337. Epub 2018 Apr 11. Expert Opin Pharmacother. 2018. PMID: 29637798 Review.
INTRODUCTION: The availability and use of long-acting reversible contraceptives (LARCs), such as levonorgestrel intrauterine systems (LNG-IUSs), have increased in recent times. ...LNG-IUS 52 mg is ideal for women who are experiencing a certain hyperestrogenic …
INTRODUCTION: The availability and use of long-acting reversible contraceptives (LARCs), such as levonorgestrel intrauterin
Long-acting reversible contraceptive (LARCs) methods.
Bahamondes L, Fernandes A, Monteiro I, Bahamondes MV. Bahamondes L, et al. Best Pract Res Clin Obstet Gynaecol. 2020 Jul;66:28-40. doi: 10.1016/j.bpobgyn.2019.12.002. Epub 2019 Dec 20. Best Pract Res Clin Obstet Gynaecol. 2020. PMID: 32014434 Review.
As the initial introduction of the inert plastic intrauterine device (IUD) and of the six-rod implant, pharmaceutical companies have introduced a copper IUD (Cu-IUD), different models of levonorgestrel-releasing intrauterine system (LNG IUS), an …
As the initial introduction of the inert plastic intrauterine device (IUD) and of the six-rod implant, pharmaceutical companie …
Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action.
Ortiz ME, Croxatto HB. Ortiz ME, et al. Contraception. 2007 Jun;75(6 Suppl):S16-30. doi: 10.1016/j.contraception.2007.01.020. Epub 2007 Mar 29. Contraception. 2007. PMID: 17531610 Review.
All intrauterine devices (IUDs) that have been tested experimentally or clinically induce a local inflammatory reaction of the endometrium whose cellular and humoral components are expressed in the tissue and the fluid filling the uterine cavity. ...Levonorgestre
All intrauterine devices (IUDs) that have been tested experimentally or clinically induce a local inflammatory reaction of the …
Pregnancy outcomes with an IUD in situ: a systematic review.
Brahmi D, Steenland MW, Renner RM, Gaffield ME, Curtis KM. Brahmi D, et al. Contraception. 2012 Feb;85(2):131-9. doi: 10.1016/j.contraception.2011.06.010. Epub 2011 Aug 16. Contraception. 2012. PMID: 22067777 Review.
BACKGROUND: While intrauterine devices (IUDs) provide highly effective contraception, pregnancies among IUD users do rarely occur. ...METHODS: We searched MEDLINE, POPLINE, EMBASE and LILACS databases from inception through April 2011 for peer-reviewed articl …
BACKGROUND: While intrauterine devices (IUDs) provide highly effective contraception, pregnancies among IUD users do ra …
Levonorgestrel-releasing intrauterine system (LNG-IUS 12) for prevention of pregnancy for up to five years.
Nelson AL. Nelson AL. Expert Rev Clin Pharmacol. 2017 Aug;10(8):833-842. doi: 10.1080/17512433.2017.1341308. Epub 2017 Jun 19. Expert Rev Clin Pharmacol. 2017. PMID: 28617060 Review.
A new five-year low dose, smaller-framed, levonorgestrel-releasing intrauterine contraceptive system (LNG-IUS 12) has been introduced to complement the currently available systems. ...On the other hand, this new IUD shares the smaller frame and narrower inser …
A new five-year low dose, smaller-framed, levonorgestrel-releasing intrauterine contraceptive system (LNG-IUS 12) has b …
Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby A, Hussain M, Rishworth JR, Rees MC. Lethaby A, et al. Cochrane Database Syst Rev. 2015 Apr 30;(4):CD002126. doi: 10.1002/14651858.CD002126.pub3. Cochrane Database Syst Rev. 2015. PMID: 25924648 Updated. Review.
OBJECTIVES: To determine the effectiveness, acceptability and safety of progesterone or progestogen-releasing intrauterine devices in achieving a reduction in heavy menstrual bleeding. ...AUTHORS' CONCLUSIONS: The levonorgestrel-releas
OBJECTIVES: To determine the effectiveness, acceptability and safety of progesterone or progestogen-releasing intrauterine
Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
Heinemann K, Reed S, Moehner S, Minh TD. Heinemann K, et al. Contraception. 2015 Apr;91(4):280-3. doi: 10.1016/j.contraception.2015.01.011. Epub 2015 Jan 16. Contraception. 2015. PMID: 25601350 Free article. Clinical Trial.
OBJECTIVES: The objective was to measure the rate of unintended pregnancies in women using levonorgestrel-releasing intrauterine systems (LNG IUSs, releasing 20 mcg LNG daily) and copper intrauterine devices (IUDs) in a typical population …
OBJECTIVES: The objective was to measure the rate of unintended pregnancies in women using levonorgestrel-releasing intraut
Use of intrauterine devices in nulliparous women.
Lohr PA, Lyus R, Prager S. Lohr PA, et al. Contraception. 2017 Jun;95(6):529-537. doi: 10.1016/j.contraception.2016.08.011. Epub 2016 Aug 31. Contraception. 2017. PMID: 27591814
Five intrauterine devices (IUDs) are available in the United States: four levonorgestrel-releasing intrauterine systems (two containing 52 mg, one containing 19.5 mg and one containing 13.5 mg) and one copper-bearing device (Copper T 380A …
Five intrauterine devices (IUDs) are available in the United States: four levonorgestrel-releasing intrauteri
The levonorgestrel-releasing intrauterine device potentiates stress reactivity.
Aleknaviciute J, Tulen JHM, De Rijke YB, Bouwkamp CG, van der Kroeg M, Timmermans M, Wester VL, Bergink V, Hoogendijk WJG, Tiemeier H, van Rossum EFC, Kooiman CG, Kushner SA. Aleknaviciute J, et al. Psychoneuroendocrinology. 2017 Jun;80:39-45. doi: 10.1016/j.psyneuen.2017.02.025. Epub 2017 Feb 28. Psychoneuroendocrinology. 2017. PMID: 28315609
BACKGROUND: The levonorgestrel-releasing intrauterine device (LNG-IUD) is currently recommended as a first-line contraceptive with an exclusively local intrauterine influence. ...Study 3-Hair cortisol was measured as a naturalistic index of l
BACKGROUND: The levonorgestrel-releasing intrauterine device (LNG-IUD) is currently recommended as a first-line …
927 results
Jump to page
Feedback